Primary mammary mucinous cystadenocarcinoma: cytological and histological findings. 2012

Kazuhiro Sentani, and Takashi Tashiro, and Naohiro Uraoka, and Yoriyuki Aosaki, and Satomi Yano, and Fumio Takaeko, and Wataru Yasui
Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.

Mucinous cystadenocarcinoma (MCA), commonly encountered in the ovary or pancreas, is rare in the breast and was only recently described as a distinct variant of invasive ductal carcinoma of the breast. Only 11 cases of primary mammary MCA have been reported. In this article, we report a case of primary mammary MCA with focus on cytological and histological findings. A 65-year-old female noticed right palpable breast mass. Sonography showed an irregularly shaped 2.8 × 2.4 cm lesion in the upper outer quadrant of the right breast. Fine-needle aspiration cytology was performed on the right breast nodule, and cytopathologic examination suggested an adenocarcinoma composed of tall columnar cells with mucin. A partial mastectomy of the right breast and the axillary lymph nodes dissection was performed. The gross examination revealed a well-demarcated and mucus-filled tumor. Histologically, it had complex papillae, some of which were supported by delicate fibrovascular stroma lined by simple to slightly stratified columnar neoplastic epithelial cells with intracellular mucin, coexisting with MCA in situ and ordinary intraductal carcinoma component (ICC). Immunohistochemically, ICC was HER2-negative and estrogen receptor/progesterone receptor-positive, while MCA was triple negative. MCA might be derived from a metaplasia of ordinary ICC, but its pathogenesis and biologic behavior remains unclear. Despite the invasive nature of mammary MCA, these carcinomas appear to be associated with a good prognosis. The patient has remained well and disease-free for 6 months after the operation.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009077 Mucins High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface. Mucin
D001940 Breast In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES. Breasts
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D044963 Biopsy, Fine-Needle Using fine needles (finer than 22-gauge) to remove tissue or fluid specimens from the living body for examination in the pathology laboratory and for disease diagnosis. Aspiration Biopsy, Fine-Needle,Fine Needle Biopsy,Fine-Needle Aspiration,Aspiration Biopsies, Fine-Needle,Aspiration Biopsy, Fine Needle,Aspiration, Fine-Needle,Aspirations, Fine-Needle,Biopsies, Fine Needle,Biopsies, Fine-Needle,Biopsies, Fine-Needle Aspiration,Biopsy, Fine Needle,Biopsy, Fine-Needle Aspiration,Fine Needle Aspiration,Fine Needle Biopsies,Fine-Needle Aspiration Biopsies,Fine-Needle Aspiration Biopsy,Fine-Needle Aspirations,Fine-Needle Biopsies,Fine-Needle Biopsy,Needle Biopsies, Fine,Needle Biopsy, Fine
D018282 Cystadenocarcinoma, Mucinous A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184) Cystadenocarcinomas, Mucinous,Mucinous Cystadenocarcinoma,Mucinous Cystadenocarcinomas

Related Publications

Kazuhiro Sentani, and Takashi Tashiro, and Naohiro Uraoka, and Yoriyuki Aosaki, and Satomi Yano, and Fumio Takaeko, and Wataru Yasui
January 2012, The breast journal,
Kazuhiro Sentani, and Takashi Tashiro, and Naohiro Uraoka, and Yoriyuki Aosaki, and Satomi Yano, and Fumio Takaeko, and Wataru Yasui
December 2006, Histopathology,
Kazuhiro Sentani, and Takashi Tashiro, and Naohiro Uraoka, and Yoriyuki Aosaki, and Satomi Yano, and Fumio Takaeko, and Wataru Yasui
October 1999, AJR. American journal of roentgenology,
Kazuhiro Sentani, and Takashi Tashiro, and Naohiro Uraoka, and Yoriyuki Aosaki, and Satomi Yano, and Fumio Takaeko, and Wataru Yasui
September 2008, Cirugia espanola,
Kazuhiro Sentani, and Takashi Tashiro, and Naohiro Uraoka, and Yoriyuki Aosaki, and Satomi Yano, and Fumio Takaeko, and Wataru Yasui
January 2006, Medicinski arhiv,
Kazuhiro Sentani, and Takashi Tashiro, and Naohiro Uraoka, and Yoriyuki Aosaki, and Satomi Yano, and Fumio Takaeko, and Wataru Yasui
February 2005, Pathology,
Kazuhiro Sentani, and Takashi Tashiro, and Naohiro Uraoka, and Yoriyuki Aosaki, and Satomi Yano, and Fumio Takaeko, and Wataru Yasui
May 1988, Cancer,
Kazuhiro Sentani, and Takashi Tashiro, and Naohiro Uraoka, and Yoriyuki Aosaki, and Satomi Yano, and Fumio Takaeko, and Wataru Yasui
January 2020, International journal of clinical and experimental pathology,
Kazuhiro Sentani, and Takashi Tashiro, and Naohiro Uraoka, and Yoriyuki Aosaki, and Satomi Yano, and Fumio Takaeko, and Wataru Yasui
February 2023, Translational cancer research,
Kazuhiro Sentani, and Takashi Tashiro, and Naohiro Uraoka, and Yoriyuki Aosaki, and Satomi Yano, and Fumio Takaeko, and Wataru Yasui
August 2014, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
Copied contents to your clipboard!